Vaccine development company working to halt AMR and STI infections.
Location: Switzerland, Zurich, Schlieren
Total raised: $39.5M
Investors 2
| Date | Name | Website |
| 08.11.2023 | Adjuvant C... | adjuvantca... |
| 29.02.2024 | CARB-X | carb-x.org |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.02.2024 | Series A | $3M | - |
| 08.10.2023 | Series A | $36.5M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 01.03.2024 | A wave of success for LimmaTech | LimmaTech is a clinical stage biotech company that has built a robust pipeline of innovative vaccin... | startuptic... |
| 02.02.2024 | New investment brings LimmaTech’s series A to CHF 40 million... | Emerging antimicrobial resistance worldwide presents a serious public health threat. Inappropriate ... | startuptic... |
| 01.02.2024 | LimmaTech Biologics Raises Additional $3M in Series A | LimmaTech Biologics, a Schlieren, Switzerland-based developer of a multi-antigen vaccine platform, r... | finsmes.co... |
| 03.01.2024 | LimmaTech Biologics expands pipeline with a vaccine against ... | startuptic... | |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 10.10.2023 | Swiss-based LimmaTech Biologics raises €35M to combat emergi... | Read this article in: Zurich-based LimmaTech Biologics AG, a clinical-stage biopharmaceutical compan... | siliconcan... |
| 09.10.2023 | First equity funding for LimmaTech Biologics | startuptic... | |
| 09.10.2023 | LimmaTech Biologics Raises $37M in Series A Funding | LimmaTech Biologics, a Schilieren, Switzerland-based biotech company developing next-generation vacc... | finsmes.co... |
| 25.07.2023 | LimmaTech signs in-license agreement with GSK | startuptic... | |
| 11.04.2022 | New prizes for Swiss startups: Applauses from home and abroa... | startuptic... |
Show more